scispace - formally typeset
N

Nakayasu Wake

Researcher at Kumamoto University

Publications -  6
Citations -  1026

Nakayasu Wake is an academic researcher from Kumamoto University. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 5, co-authored 6 publications receiving 999 citations.

Papers
More filters
Journal Article

Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

TL;DR: Intensive glycemic control can delay the onset and progression of the early stages of diabetic microvascular complications in Japanese patients with type 2 diabetes.
Journal ArticleDOI

Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes

TL;DR: Hyperglycemia independently increases 8-OHdG in patients with type 2 diabetes, and this biomarker is a useful biomarker of not only microvascular but also macrovascular complications in Patients withType 2 diabetes.
Journal ArticleDOI

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.

TL;DR: Economic evaluation of a randomized controlled trial on the prevention of diabetes complications in Japan shows that MIT is more beneficial than CIT in both cost and effectiveness, and is recommended for the treatment of type 2 diabetic patients who require insulin therapy as early as possible.
Journal ArticleDOI

Thyroxine-binding globulin variant (TBG-Kumamoto): identification of a point mutation and genotype analysis of its family.

TL;DR: A Japanese female patient with hyperthyroid state, whose lower TBG levels did not return to normal under the euthyroid state after treatment, is examined, and a single nucleotide substitution in the codon for the amino acid 363 of native TBG molecule was found, resulting in the replacement of proline by leucine.